Si è svolto online il 26 marzo l'evento Pitch & Partner, al quale si sono registrati 73 Colleghi con una nutrita presenza internazionale.
Due le sessioni: al mattino le aziende hanno presentato i loro progetti, introdotte da Claudia Rinaldi, Presidente IHLG e da Rachid BenHamza, Presidente IPLS.
Nel corso del pomeriggio spazio agli incontri 1-to-1, che sono stati 55.
Le presentazioni sono disponibili in Area Riservata/Materiali/Webinar al seguente link: https://www.italyhlg.it/index.php/area-riservata/materiali/107-webinar/246-italy-hlg-pitch-partner-online-event-26th-march-2021
Vi ricordiamo le presentazioni in programma: Breakthrough in Hyaluronan applications ( BMG Pharma, Marco Mastrodonato, Founder & CEO), GERDOFF® - From SOFAR’s research a novel therapy for GERD patients (Sofar, Antonella Cimatti, Business Development Manager), Digital Therapeutics, new ways to expand pharma portfolio strategies (Plexus Ventures, Gabriele Tundo, Vice President), Shedir Pharma Group (Shedir Pharma, Antonio Scala, CEO), NTC company presentation and its portfolio: a leading player in ophthalmology with selected innovation in dermatology, gynecology, gastroenterology and pediatry (NTC, Riccardo Carbucicchio, CEO), Innovation in functional oral care (Metis Healthcare, Cristiano Rumio, CEO), Development and Clinical Evaluation of Macrogol 4000 for Rectal Administration as New Treatment for Constipation (New.Fa.Dem., Cristian Salvatore, R&D and Regulatory Affairs Director), Fulton – A fully Italian integrated CDMO (Fulton Medicinali, Simone Sarno, Business Development Manager), Proge Farm’s approach to bacteria-based products: biotherapeutics (Proge Farm, Giancarla Dondi, CEO).